Bronchiectasis: A continuum of ion transport dysfunction or multiple hits?

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 10, 2010, Pages 1017-1019

  Boucher, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL SODIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

AIRWAY; BRONCHIECTASIS; CHLORIDE TRANSPORT; DISEASE EXACERBATION; EDITORIAL; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC VARIABILITY; HUMAN; ION TRANSPORT; LUNG FIBROSIS; PHENOTYPE; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; SODIUM TRANSPORT; GENETICS; METABOLISM; MUTATION; NOTE;

BRONCHIECTASIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; ION TRANSPORT; MUTATION;

EID: 77953280986     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201002-0284ED     Document Type: Editorial

References (17)

1. Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I. CFTR channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 181:1078-1084.
2. Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, Lazarowski ER, Zhang L, Collins PL, Pickles RJ, Fredberg JJ, et al. Normal and cystic fibrosis airway surface liquid homeostasis: the effects of phasic shear stress and viral infections. J Biol Chem 2005;280:35751-35759. (Pubitemid 41532768)
3. Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 2007;58:157-170. (Pubitemid 46706507)
4. Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, Bowers A, Naughton K, Jennings J, Ellen J, Cutting GR. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 2008;299:417-424. (Pubitemid 351185950)
5. Collaco JM, Cutting GR. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 2008;14:559-566.
6. Gray T, Coakley R, Hirsh A, Thornton D, Kirkham S, Koo JS, Burch L, Boucher R, Nettesheim P. Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1b in human bronchial epithelia. Am J Physiol 2004;286:L320-L330. (Pubitemid 38129513)
7. Fajac I, Viel M, Sublemontier S, Hubert D, Bienvenu T. Could a defective epithelial sodium channel lead to bronchiectasis. Respir Res 2008;9:46.
8. + channels carrying Liddle's syndrome mutations. J Biol Chem 1999;274:13894-13899.
9. + absorption and absence of pulmonary disease in the airways of patients with Liddle's syndrome: potential role of CFTR [abstract]. Pediatr Pulmonol 1998;Suppl. 17:217.
10. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004;10:487-493.
11. Livraghi A, Klem ER, Hudson EJ, Wilkinson KJ, Wolfgang MC, Boucher RC, Randell SH. Genetic deletion of MYD88-mediated signaling in ΔENaC over-expressing mice reduces airway neutrophilia but promotes spontaneous, mucus-associated bacterial infection [abstract]. Pediatr Pulmonol 2008;Suppl. 31:262.
12. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, LeGrys VA, Massie J, Parad RB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-S14. (Pubitemid 351970581)
13. Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001;17:1208-1215. (Pubitemid 32717480)
14. Boucher RC. Human airway ion transport. Part 1. Am J Respir Crit Care Med 1994;150:271-281.
15. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 2006;44:2601-2604. (Pubitemid 44092439)
16. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, XuanW, Bye PTP; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of longterm inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354:229-240.
17. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006;354:241-250. (Pubitemid 43113029)